Galmed Pharma (GLMD) Earnings
|
Expand Research on GLMD
Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +13.3% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -10.1% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
5/8/24 | Q124 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
3/14/24 | Q423 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
3/18/24 | Q423 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
3/25/24 | Q423 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/6/23 | Q323 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/13/23 | Q323 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/27/23 | Q323 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/20/23 | Q323 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A |